Cargando…
Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach
OBJECTIVES: To quantify the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. DESIGN: Modelling and validation of the lifetime risk method using publicly available population data. SETTING: Opportunistic screening for prostate cancer i...
Autores principales: | Pathirana, Thanya, Hayen, Andrew, Doust, Jenny, Glasziou, Paul, Bell, Katy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429722/ https://www.ncbi.nlm.nih.gov/pubmed/30858156 http://dx.doi.org/10.1136/bmjopen-2018-022457 |
Ejemplares similares
-
Estimating the magnitude of cancer overdiagnosis in Australia
por: Glasziou, Paul P, et al.
Publicado: (2019) -
Including Information on Overdiagnosis in Shared Decision Making: A
Review of Prostate Cancer Screening Decision Aids
por: Pathirana, Thanya I., et al.
Publicado: (2022) -
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
por: Pashayan, Nora, et al.
Publicado: (2015) -
Complexities in the estimation of overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2008) -
Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia
por: Pashayan, N, et al.
Publicado: (2006)